$CGIX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vyant Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Vyant Bio, Inc.. Get notifications about new insider transactions in Vyant Bio, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 16 2015 | CGIX | CANCER GENETICS, I ... | Chaganti Raju S.K. | Director | Option Exercise | A | 7.80 | 10,000 | 78,000 | 10,000 | |
Oct 16 2015 | CGIX | CANCER GENETICS, I ... | Chaganti Raju S.K. | Director | Grant | A | 0.00 | 2,500 | 0 | 174,181 | 171.7 K to 174.2 K (+1.46 %) |
Oct 16 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 7.80 | 10,000 | 78,000 | 10,000 | |
Oct 16 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Grant | A | 0.00 | 2,500 | 0 | 1,521,789 | 1.5 M to 1.5 M (+0.16 %) |
Aug 27 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 10.25 | 2,500 | 25,624 | 1,519,289 | 1.5 M to 1.5 M (+0.16 %) |
Aug 27 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 8.97 | 2,500 | 22,436 | 1,516,789 | 1.5 M to 1.5 M (+0.17 %) |
Jul 13 2015 | CGIX | CANCER GENETICS, I ... | Shaknovich Rita | VP of Hematopatholo ... | Option Exercise | A | 11.36 | 12,000 | 136,320 | 12,000 | |
Jul 13 2015 | CGIX | CANCER GENETICS, I ... | Shaknovich Rita | VP of Hematopatholo ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Jun 26 2015 | CGIX | CANCER GENETICS, I ... | Chaganti Raju S.K. | Director | Sell | S | 12.00 | 5,296 | 63,552 | 171,681 | 177 K to 171.7 K (-2.99 %) |
Jun 15 2015 | CGIX | CANCER GENETICS, I ... | Chaganti Raju S.K. | Director | Sell | S | 12.01 | 7,000 | 84,052 | 176,977 | 184 K to 177 K (-3.80 %) |
Jun 11 2015 | CGIX | CANCER GENETICS, I ... | Chaganti Raju S.K. | Director | Sell | S | 12.05 | 15,900 | 191,519 | 137,523 | 153.4 K to 137.5 K (-10.36 %) |
Jun 11 2015 | CGIX | CANCER GENETICS, I ... | Chaganti Raju S.K. | Director | Sell | S | 12.03 | 22,817 | 274,400 | 153,423 | 176.2 K to 153.4 K (-12.95 %) |
Jun 11 2015 | CGIX | CANCER GENETICS, I ... | Chaganti Raju S.K. | Director | Sell | S | 12.01 | 7,737 | 92,944 | 176,240 | 184 K to 176.2 K (-4.21 %) |
Jun 11 2015 | CGIX | CANCER GENETICS, I ... | Hepburn Steven | VP of Biopharma Mar ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Jun 09 2015 | CGIX | CANCER GENETICS, I ... | Chaganti Raju S.K. | Director | Sell | S | 12.03 | 24,583 | 295,670 | 159,394 | 184 K to 159.4 K (-13.36 %) |
May 18 2015 | CGIX | CANCER GENETICS, I ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 10.74 | 10,000 | 107,400 | 10,000 | |
May 18 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 10.74 | 5,000 | 53,700 | 1,519,289 | 1.5 M to 1.5 M (+0.33 %) |
May 18 2015 | CGIX | CANCER GENETICS, I ... | Cannon Edmund | Director | Option Exercise | A | 10.74 | 10,000 | 107,400 | 10,000 | |
May 18 2015 | CGIX | CANCER GENETICS, I ... | Welsh Michael J. | Director | Option Exercise | A | 10.74 | 10,000 | 107,400 | 10,000 | |
May 18 2015 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Option Exercise | A | 10.74 | 10,000 | 107,400 | 10,000 | |
May 18 2015 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
May 18 2015 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Buy | P | 10.79 | 5,000 | 53,949 | 5,000 | 0 to 5 K |
May 18 2015 | CGIX | CANCER GENETICS, I ... | McLeod Howard | Director | Option Exercise | A | 10.74 | 10,000 | 107,400 | 10,000 | |
May 18 2015 | CGIX | CANCER GENETICS, I ... | McLeod Howard | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Mar 18 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 7.15 | 15,000 | 107,237 | 1,514,289 | 1.5 M to 1.5 M (+1.00 %) |
Mar 18 2015 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 7.45 | 35,000 | 260,586 | 1,499,289 | 1.5 M to 1.5 M (+2.39 %) |
Mar 18 2015 | CGIX | CANCER GENETICS, I ... | Sitar Edward J | Chief Financial Off ... | Buy | P | 6.99 | 1,000 | 6,992 | 12,500 | 11.5 K to 12.5 K (+8.70 %) |
Dec 17 2014 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 6.20 | 5,589 | 34,652 | 1,464,289 | 1.5 M to 1.5 M (+0.38 %) |
Dec 16 2014 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 6.14 | 3,634 | 22,313 | 1,458,700 | 1.5 M to 1.5 M (+0.25 %) |
Dec 15 2014 | CGIX | CANCER GENETICS, I ... | McLeod Howard | Director | Option Exercise | A | 6.30 | 5,000 | 31,500 | 5,000 | |
Dec 15 2014 | CGIX | CANCER GENETICS, I ... | El Naggar Jane Houldsworth | VP of Research and ... | Option Exercise | A | 6.30 | 10,000 | 63,000 | 10,000 | |
Dec 15 2014 | CGIX | CANCER GENETICS, I ... | Harris Geoffrey E. | Director | Option Exercise | A | 6.30 | 5,000 | 31,500 | 5,000 | |
Dec 15 2014 | CGIX | CANCER GENETICS, I ... | SHARMA PANNA | Chief Executive Off ... | Option Exercise | A | 6.30 | 250,000 | 1,575,000 | 250,000 | |
Dec 15 2014 | CGIX | CANCER GENETICS, I ... | SHARMA PANNA | Chief Executive Off ... | Grant | A | 0.00 | 100,000 | 0 | 150,000 | 50 K to 150 K (+200.00 %) |
Dec 15 2014 | CGIX | CANCER GENETICS, I ... | Sitar Edward J | Chief Financial Off ... | Option Exercise | A | 6.30 | 90,000 | 567,000 | 90,000 | |
Dec 15 2014 | CGIX | CANCER GENETICS, I ... | Sitar Edward J | Chief Financial Off ... | Buy | P | 6.26 | 500 | 3,130 | 11,500 | 11 K to 11.5 K (+4.55 %) |
Dec 12 2014 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 6.03 | 27,087 | 163,335 | 1,455,066 | 1.4 M to 1.5 M (+1.90 %) |
Dec 11 2014 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 5.96 | 5,773 | 34,407 | 1,427,979 | 1.4 M to 1.4 M (+0.41 %) |
Dec 10 2014 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 5.70 | 15,986 | 91,120 | 1,422,206 | 1.4 M to 1.4 M (+1.14 %) |
Dec 10 2014 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 5.11 | 23,700 | 121,107 | 1,406,220 | 1.4 M to 1.4 M (+1.71 %) |
May 27 2014 | CGIX | CANCER GENETICS, I ... | Sitar Edward J | CFO, Secretary & Tr ... | Option Exercise | A | 17.62 | 90,000 | 1,585,800 | 90,000 | |
May 27 2014 | CGIX | CANCER GENETICS, I ... | Sitar Edward J | CFO, Secretary & Tr ... | Grant | A | 0.00 | 10,000 | 0 | 11,000 | 1,000 to 11 K (+1,000.00 %) |
Jun 12 2014 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Option Exercise | M | 4.00 | 44,288 | 177,152 | 0 | |
Jun 12 2014 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | M | 4.00 | 44,288 | 177,152 | 1,382,520 | 1.3 M to 1.4 M (+3.31 %) |
May 27 2014 | CGIX | CANCER GENETICS, I ... | Rothman Paul | Director | Option Exercise | A | 11.70 | 10,000 | 117,000 | 10,000 | |
May 27 2014 | CGIX | CANCER GENETICS, I ... | Rothman Paul | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
May 27 2014 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 13.98 | 100,000 | 1,398,000 | 100,000 | |
May 27 2014 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Grant | A | 0.00 | 25,000 | 0 | 1,338,232 | 1.3 M to 1.3 M (+1.90 %) |
May 27 2014 | CGIX | CANCER GENETICS, I ... | SHARMA PANNA | President & CEO | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
May 27 2014 | CGIX | CANCER GENETICS, I ... | Cannon Edmund | Director | Grant | A | 0.00 | 5,000 | 0 | 10,894 | 5.9 K to 10.9 K (+84.83 %) |
May 27 2014 | CGIX | CANCER GENETICS, I ... | Chaganti Raju S.K. | Director | Option Exercise | A | 15.89 | 200,000 | 3,178,000 | 200,000 | |
May 27 2014 | CGIX | CANCER GENETICS, I ... | PRENDERGAST FRANKLYN G | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
May 27 2014 | CGIX | CANCER GENETICS, I ... | Brownlie Keith L | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
May 22 2014 | CGIX | CANCER GENETICS, I ... | Sitar Edward J | Chief Financial Off ... | Buy | P | 10.67 | 1,000 | 10,670 | 1,000 | 0 to 1,000 |
May 21 2014 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 10.66 | 5,000 | 53,300 | 1,313,232 | 1.3 M to 1.3 M (+0.38 %) |
May 21 2014 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 10.35 | 30,000 | 310,500 | 1,308,232 | 1.3 M to 1.3 M (+2.35 %) |
May 21 2014 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 10.10 | 15,000 | 151,500 | 1,278,232 | 1.3 M to 1.3 M (+1.19 %) |
Nov 20 2013 | CGIX | CANCER GENETICS, I ... | Pecora Andrew L | Director | Sell | S | 15.51 | 1,700 | 26,375 | 2,391 | 4.1 K to 2.4 K (-41.55 %) |
Nov 20 2013 | CGIX | CANCER GENETICS, I ... | Pecora Andrew L | Director | Sell | S | 14.10 | 29,161 | 411,217 | 4,091 | 33.3 K to 4.1 K (-87.70 %) |
Nov 20 2013 | CGIX | CANCER GENETICS, I ... | Pecora Andrew L | Director | Sell | S | 14.40 | 18,839 | 271,225 | 33,252 | 52.1 K to 33.3 K (-36.17 %) |
Nov 20 2013 | CGIX | CANCER GENETICS, I ... | Pecora Andrew L | Director | Sell | S | 15.11 | 300 | 4,532 | 52,091 | 52.4 K to 52.1 K (-0.57 %) |
Oct 15 2013 | CGIX | CANCER GENETICS, I ... | PRENDERGAST FRANKLYN G | Director | Option Exercise | A | 15.39 | 10,000 | 153,900 | 10,000 | |
Oct 15 2013 | CGIX | CANCER GENETICS, I ... | SHARMA PANNA | Chief Executive Off ... | Option Exercise | A | 15.39 | 200,000 | 3,078,000 | 200,000 | |
Oct 15 2013 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Option Exercise | A | 15.39 | 10,000 | 153,900 | 10,000 | |
Oct 15 2013 | CGIX | CANCER GENETICS, I ... | Pecora Andrew L | Director | Option Exercise | A | 15.39 | 10,000 | 153,900 | 10,000 | |
Oct 15 2013 | CGIX | CANCER GENETICS, I ... | Cannon Edmund | Director | Option Exercise | A | 15.39 | 10,000 | 153,900 | 10,000 | |
Oct 15 2013 | CGIX | CANCER GENETICS, I ... | El Naggar Jane Houldsworth | VP of Research and ... | Option Exercise | A | 15.39 | 10,000 | 153,900 | 10,000 | |
Oct 15 2013 | CGIX | CANCER GENETICS, I ... | Brownlie Keith L | Director | Option Exercise | A | 15.39 | 10,000 | 153,900 | 22,312 | |
Oct 15 2013 | CGIX | CANCER GENETICS, I ... | Brownlie Keith L | Director | Option Exercise | A | 15.39 | 12,312 | 189,482 | 12,312 | |
Oct 15 2013 | CGIX | CANCER GENETICS, I ... | Thompson Tommy G | Director | Option Exercise | A | 15.39 | 10,000 | 153,900 | 10,000 | |
Oct 15 2013 | CGIX | CANCER GENETICS, I ... | Thompson Tommy G | Director | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Apr 12 2013 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Option Exercise | C | 13.20 | 377,789 | 4,986,815 | 0 | |
Apr 12 2013 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | C | 0.00 | 80,686 | 0 | 1,263,232 | 1.2 M to 1.3 M (+6.82 %) |
Apr 12 2013 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 0.00 | 200,000 | 0 | 1,182,546 | 982.5 K to 1.2 M (+20.36 %) |
Apr 12 2013 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 0.00 | 200,000 | 0 | 982,546 | 782.5 K to 982.5 K (+25.56 %) |
Apr 12 2013 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 0.00 | 100,000 | 0 | 782,546 | 682.5 K to 782.5 K (+14.65 %) |
Apr 12 2013 | CGIX | CANCER GENETICS, I ... | PAPPAJOHN JOHN | Director | Buy | P | 0.00 | 175,000 | 0 | 682,546 | 507.5 K to 682.5 K (+34.48 %) |
Apr 12 2013 | CGIX | CANCER GENETICS, I ... | Chaganti Raju S.K. | Director | Buy | P | 0.00 | 13,430 | 0 | 438,727 | 425.3 K to 438.7 K (+3.16 %) |
Apr 12 2013 | CGIX | CANCER GENETICS, I ... | Pecora Andrew L | Director | Buy | P | 0.00 | 50,000 | 0 | 52,391 | 2.4 K to 52.4 K (+2,091.18 %) |